Nuevolution

Please note: The information displayed on this page might be outdated.
Nuevolution: Scandinavian biopharmaceutical company focused on developing drug treatments for human diseases within oncology and chronic inflammatory diseases. We have set our focus and objectives to be:
Realization of efficacious, safer, tablet based, and lower cost medicines, for treatment of severe chronic inflammatory diseases like e.g. multiple sclerosis (MS), rheumatoid arthritis (RA), psoriasis (PsO), inflamed fatty liver (NASH) and chronic inflamed colon or intestine (IBD) where significant unmet medical need remains.
Sector/Industry:
Healthcare/Biotechnology
Characteristics:
Based in...
Europe
Listing
Public
Website:
Profiles:
Address:
Rønnegade 8
Copenhagen, Hovedstaden 2100
Denmark

Company Participants at Danish Science and The City DKBIO 17

  • Alex Gouliaev, CEO
Ownership data is sourced through FactSet.

Stock Market Data

Data is being loaded...
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2021 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, RTB=Real-Time BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.